{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:53:36Z","timestamp":1762865616033},"reference-count":42,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1016\/j.diagmicrobio.2009.12.009","type":"journal-article","created":{"date-parts":[[2010,4,11]],"date-time":"2010-04-11T08:34:50Z","timestamp":1270974890000},"page":"78-86","source":"Crossref","is-referenced-by-count":23,"title":["Antimicrobial activity against Streptococcus pneumoniae and Haemophilus influenzae collected globally between 2004 and 2008 as part of the Tigecycline Evaluation and Surveillance Trial"],"prefix":"10.1016","volume":"67","author":[{"given":"Ali","family":"Darabi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Didier","family":"Hocquet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Dowzicky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2009.12.009_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkf801","article-title":"Global antibiotic resistance in Streptococcus pneumoniae","volume":"50","author":"Adam","year":"2002","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.diagmicrobio.2009.12.009_bib2","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.diagmicrobio.2008.09.001","article-title":"Safety and efficacy of intravenous tigecycline in treatment of community-acquired pneumonia: results from a double-blind randomized phase 3 comparison study with levofloxacin","volume":"63","author":"Bergallo","year":"2009","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2009.12.009_bib3","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0732-8893(03)00016-6","article-title":"Five-year analysis of Haemophilus influenzae isolates with reduced susceptibility to fluoroquinolones: prevalence results from the SENTRY antimicrobial surveillance program","volume":"46","author":"Biedenbach","year":"2003","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2009.12.009_bib4","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1093\/jac\/dki134","article-title":"Comparative in vitro antimicrobial activity of a new carbapenem, doripenem: tentative disc diffusion criteria and quality control","volume":"55","author":"Brown","year":"2005","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.diagmicrobio.2009.12.009_bib5","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1179\/joc.2007.19.5.482","article-title":"Comparative in vitro activity of tigecycline against aerobic and facultative isolates recovered from hospitalized patients: an Argentinean multicentre study","volume":"19","author":"Casellas","year":"2007","journal-title":"J. Chemother."},{"key":"10.1016\/j.diagmicrobio.2009.12.009_bib6","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1128\/AAC.00335-07","article-title":"First characterisation of heterogeneous resistance to imipenem in invasive nontypeable Haemophilus influenzae isolates","volume":"51","author":"Cerquetti","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2009.12.009_bib7","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1128\/AAC.01563-06","article-title":"Increasing ceftriaxone resistance and multiple alterations of penicillin-binding proteins among penicillin-resistant Streptococcus pneumoniae in Taiwan","volume":"51","author":"Chiu","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2009.12.009_bib8","series-title":"Performance standard for antimicrobial susceptibility testing, document M100-S16","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2006"},{"key":"10.1016\/j.diagmicrobio.2009.12.009_bib9","series-title":"Performance standard for antimicrobial susceptibility testing, document M100-S18","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2008"},{"key":"10.1016\/j.diagmicrobio.2009.12.009_bib10","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.ijantimicag.2005.02.013","article-title":"Steady-state serum and intrapulmonary pharmacokinetics and pharmacodynamics of tigecycline","volume":"25","author":"Conte","year":"2005","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.diagmicrobio.2009.12.009_bib11","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1128\/AAC.47.3.972-978.2003","article-title":"Efflux-Mediated Resistance to Tigecycline (GAR-936) in Pseudomonas aeruginosa PAO1","volume":"47","author":"Dean","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2009.12.009_bib12","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1086\/430906","article-title":"Antimicrobial resistance among Streptococcus pneumoniae in the United States: have we begun to turn the corner on resistance to certain antimicrobial classes?","volume":"41","author":"Doern","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2009.12.009_bib13","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000118660","article-title":"Baseline in vitro activity of tigecycline among key bacterial pathogens exhibiting multidrug resistance","volume":"54","author":"Draghi","year":"2008","journal-title":"Chemotherapy"},{"key":"10.1016\/j.diagmicrobio.2009.12.009_bib14","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jinf.2007.04.006","article-title":"Regional trends in \u03b2-lactam, macrolide, fluoroquinolone and telithromycin resistance among Streptococcus pneumoniae isolates 2001\u20132004","volume":"55","author":"Felmingham","year":"2007","journal-title":"J. Infect."},{"key":"10.1016\/j.diagmicrobio.2009.12.009_bib15","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.diagmicrobio.2005.05.004","article-title":"Antimicrobial activity of tigecycline tested against organisms causing community-acquired respiratory tract infection and nosocomial pneumonia","volume":"52","author":"Fritsche","year":"2005","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2009.12.009_bib16","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1159\/000214144","article-title":"Comparison of in vitro activities of tigecycline with other antimicrobial agents against Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis in two university hospitals in Istanbul, Turkey","volume":"55","author":"Gonullu","year":"2009","journal-title":"Chemotheraphy"},{"key":"10.1016\/j.diagmicrobio.2009.12.009_bib17","first-page":"537","article-title":"Resistance to newer beta-lactams and related ESBL types in gram-negative nosocomial isolates in Turkish hospitals: results of the multicentre HITIT study","volume":"42","author":"G\u00fcr","year":"2008","journal-title":"Mikrobiyol. Bul."},{"key":"10.1016\/j.diagmicrobio.2009.12.009_bib18","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1086\/320181","article-title":"Worldwide prevalence of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the SENTRY Antimicrobial Surveillance Program, 1997\u20131999","volume":"32","author":"Hoban","year":"2001","journal-title":"Clin. Infect. Dis."},{"issue":"Suppl S1","key":"10.1016\/j.diagmicrobio.2009.12.009_bib19","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/jac\/dkf810","article-title":"The PROTEKT surveillance study: antimicrobial susceptibility of Haemophilus influenzae and Moraxella catarrhalis from community-acquired respiratory tract infections","volume":"50","author":"Hoban","year":"2002","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.diagmicrobio.2009.12.009_bib20","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0732-8893(03)00089-0","article-title":"Susceptibility trends of Haemophilus influenzae and Moraxella catarrhalis against orally administered antimicrobial agents: five-year report from the SENTRY Antimicrobial Surveillance Program","volume":"47","author":"Johnson","year":"2003","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2009.12.009_bib21","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1128\/AAC.00960-06","article-title":"Diversity of ampicillin resistance genes and antimicrobial susceptibility patterns in Haemophilus influenzae strains isolates in Korea","volume":"51","author":"Kim","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2009.12.009_bib22","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.diagmicrobio.2006.02.001","article-title":"Antimicrobial activity of tigecycline against recent isolates of respiratory pathogens from Asian countries","volume":"55","author":"Ko","year":"2006","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2009.12.009_bib23","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1089\/mdr.2006.12.130","article-title":"Comparison of in vitro activities of tigecycline with other antimicrobial agents against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in Taiwan","volume":"12","author":"Lau","year":"2006","journal-title":"Microb. Drug Resist."},{"issue":"Suppl 2","key":"10.1016\/j.diagmicrobio.2009.12.009_bib24","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1086\/511159","article-title":"Infectious Diseases Society of America\/American Thoracic Society Consensus Guidelines on the management of community-acquired pneumonia in adults","volume":"44","author":"Mandell","year":"2007","journal-title":"Clin. Infect. Dis."},{"issue":"Suppl 1","key":"10.1016\/j.diagmicrobio.2009.12.009_bib25","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/S0924-8579(07)70003-1","article-title":"Recent findings from multinational resistance surveys: are we \u2018PROTEKTed\u2019 from resistance?","volume":"29","author":"Marchese","year":"2007","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.diagmicrobio.2009.12.009_bib26","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.2165\/0003495-200868180-00008","article-title":"Tigecycline: in community-acquired pneumonia","volume":"68","author":"McKeage","year":"2008","journal-title":"Drugs"},{"key":"10.1016\/j.diagmicrobio.2009.12.009_bib27","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1093\/jac\/48.5.723","article-title":"In vitro and in vivo activities of meropenem and comparable antimicrobial agents against Haemophilus influenzae, including \u03b2-lactamase\u2013negative ampicillin-resistant strains","volume":"48","author":"Miyazaki","year":"2001","journal-title":"J. Antimicrob. Chemother."},{"issue":"Suppl 2","key":"10.1016\/j.diagmicrobio.2009.12.009_bib28","doi-asserted-by":"crossref","first-page":"ii97","DOI":"10.1093\/jac\/dkn356","article-title":"Non-susceptibility trends among Haemophilus influenzae and Moraxella catarrhalis from community-acquired respiratory tract infections in the UK and Ireland, 1999\u20132007","volume":"62","author":"Morrissey","year":"2008","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.diagmicrobio.2009.12.009_bib29","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jhin.2005.01.007","article-title":"Acinetobacter baumannii: emergence and spread in Israeli hospitals 1997\u20132002","volume":"60","author":"Paul","year":"2005","journal-title":"J. Hosp. Infect."},{"key":"10.1016\/j.diagmicrobio.2009.12.009_bib30","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1128\/AAC.01198-06","article-title":"Tigecycline efflux as a mechanism for nonsusceptibility in Acinetobacter baumannii","volume":"51","author":"Peleg","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"issue":"Suppl 3","key":"10.1016\/j.diagmicrobio.2009.12.009_bib31","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1469-0691.2009.02724.x","article-title":"The antimicrobial resistance profile of Streptococcus pneumoniae","volume":"15","author":"Reinert","year":"2009","journal-title":"Clin. Microbiol. Infect."},{"issue":"Suppl 6","key":"10.1016\/j.diagmicrobio.2009.12.009_bib32","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1186\/cc7025","article-title":"Demographics, guidelines, and clinical experience in severe community-acquired pneumonia","volume":"12","author":"Rello","year":"2008","journal-title":"Crit. Care"},{"key":"10.1016\/j.diagmicrobio.2009.12.009_bib33","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1086\/595857","article-title":"Changing epidemiology of antimicrobial-resistant Streptococcus pneumoniae in the United States, 2004\u20132005","volume":"48","author":"Richter","year":"2009","journal-title":"Clin. Infect. Dis."},{"issue":"Suppl 3","key":"10.1016\/j.diagmicrobio.2009.12.009_bib34","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3810\/pgm.2008.09.suppl52.279","article-title":"Tracking resistance among bacterial respiratory tract pathogens: summary of findings of the TRUST surveillance initiative, 2001\u20132005","volume":"120","author":"Sahm","year":"2008","journal-title":"Postgrad. Med."},{"issue":"Suppl 3","key":"10.1016\/j.diagmicrobio.2009.12.009_bib35","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3810\/pgm.2008.09.suppl52.280","article-title":"Antimicrobial susceptibility profiles among common respiratory tract pathogens: a GLOBAL perspective","volume":"120","author":"Sahm","year":"2008","journal-title":"Postgrad. Med."},{"key":"10.1016\/j.diagmicrobio.2009.12.009_bib36","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1128\/AAC.01316-05","article-title":"Molecular evolution of \u03b2-lactam resistant Haemophilus influenzae: 9-year surveillance of penicillin-binding protein 3 mutations in isolates from Japan","volume":"50","author":"Sanbongi","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2009.12.009_bib37","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.diagmicrobio.2008.04.009","article-title":"Integrated results of 2 phase 3 studies comparing tigecycline and levofloxacin in community-acquired pneumonia","volume":"61","author":"Tanaseanu","year":"2008","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2009.12.009_bib38","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1128\/CMR.00040-06","article-title":"Antimicrobial resistance in Haemophilus influenzae","volume":"20","author":"Tristram","year":"2007","journal-title":"Clin. Microbiol. Rev."},{"issue":"Suppl 3","key":"10.1016\/j.diagmicrobio.2009.12.009_bib39","doi-asserted-by":"crossref","first-page":"S184","DOI":"10.1016\/S0924-8579(08)70025-6","article-title":"Nationwide surveillance in Taiwan of the in-vitro activity of tigecycline against clinical isolates of Gram-positive cocci","volume":"32","author":"Tsao","year":"2008","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.diagmicrobio.2009.12.009_bib40","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1128\/AAC.47.2.665-669.2003","article-title":"AcrAB multidrug efflux pump is associated with reduced levels of susceptibility to tigecycline (GAR-936) in Proteus mirabilis","volume":"47","author":"Visalli","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2009.12.009_bib41","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1469-0691.2007.01946.x","article-title":"Associated antimicrobial resistance in Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus pneumoniae and Streptococcus pyogenes","volume":"14","author":"Wimmerstedt","year":"2008","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.diagmicrobio.2009.12.009_bib42","author":"Wyeth Pharmaceuticals Inc"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889309004866?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889309004866?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,12]],"date-time":"2018-12-12T01:54:24Z","timestamp":1544579664000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889309004866"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["S0732889309004866"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2009.12.009","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]}}}